Dear Colleague
The second update of concessionary prices were granted for March 2022:
DrugPack SizeConcessionary Price
Aqueous cream100£0.75
Co-trimoxazole 80mg/400mg tablets28£2.10
Cyanocobalamin 50microgram tablets50£14.49
Fludrocortisone 100microgram tablets30£9.70
Isotretinoin 20mg capsules30£16.30
Lacidipine 2mg tablets28£2.95
Liothyronine 5microgram tablets28£100.94
Naftidrofuryl 100mg capsules84£8.10
Nortriptyline 10mg tablets100£1.91
Nortriptyline 25mg tablets100£1.81
Prasugrel 10mg tablets28£10.80
Pravastatin 10mg tablets28£0.99
Solifenacin 5mg tablets30£2.30
Sulfasalazine 250mg/5ml oral suspension sugar free500£94.22
Tamoxifen 10mg/5ml oral solution sugar free150£74.52
Valsartan 160mg capsules28£7.74

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
DR. GARETH C. GILVARY
Governance & Support Pharmacist

25 March 2022

BSO ALERTS 

Weekly Drug Alerts are available here.

Weekly Shortages Information is available here.

Serious Shortage Protocols are available here.

CPNI ALERTS 

HSCB ALERTS
Letter from Mr Canice Ward re MRG compliance visits to Community Pharmacies 25 March 2022
Letter from Mr Richard Pengelly re DONATIONS OF MEDICINES AND MEDICAL SUPPLIES TO UKRAINE 25 March 2022
Pharmacy First Service for Everyday Health Conditions 14 March 2022

Please bring this to the attention of your pharmacy team(s).

Pharmacy team(s) can keep updated via CPNI’s:
Contractor Calendar
Contractor Emails

Or report medicine shortages, pricing and staffing issues via CPNI’s:
Medicine Shortage Reporter
Situation Reporter

Kind regards

SENT ON BEHALF OF 
DR. GARETH C. GILVARY
Governance & Support Pharmacist

25 March 2022

Dear Colleague

Please find correspondence HERE which issued today from HSCB Pharmacy & Medicines Management.  The letter referred to in the correspondence is available here for your convenience.

ACTION

Contractors are asked to review the correspondence and in particular note that  MRG will resume its pre-Covid compliance activities from 1 April 2022. The Inspectors will continue to wear Personal Protective Equipment and will maintain social distancing where possible. The situation will be kept under constant review in light of the extant public health advice.

Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

Mr Gerard Greene

Chief Executive

25 March 2022

Dear Colleague

Please find correspondence HERE which issued today from HSCB Pharmacy & Medicines Management. 

The correspondence includes a link to a letter outlining plans for the COVID-19 Spring Booster Vaccination Programme.  The letter is available here for your convenience.

ACTION

  • Contractors are asked to review the correspondence noting in particular paragraphs 6, 9 and 12 which contain information relevant to those community pharmacies providing Covid vaccination services.

Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

Gerard Greene

Chief Executive

Thursday 24 March 2022

Dear Colleague

Please find correspondence HERE which issued today from HSCB Pharmacy & Medicines Management.

As the link in the email directs to the primary care intranet, the key documents are linked here for your convenience:

– SRP Phase 2 Survey
– Appendix 1

Note:  Surveys are to be returned by 31 March 2022 to: StaffRecognitionPaymentQueries@hscni.net


ACTION

  • Contractors are asked to review the correspondence.
  • Submit any relevant returns to  StaffRecognitionPaymentQueries@hscni.net by 31 March 2022

Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards,

GERARD GREENE
Chief Executive

Dear Colleague

Pharmacy Collect NI (LFD) – Extension of Service

DOH has confirmed an extension to the ‘Pharmacy Collect NI’ service until at least 22 April 2022.

The Health Minister today published a Test and Trace Transition Plan. This is based on the latest public health advice and signals a move to a more targeted service, focused on protecting the most vulnerable people and those at highest risk of serious illness should they contract COVID-19.

The first changes will take place from 22 April 2022, with further changes planned through to the end of June 2022.

The Minister recognises the key role that Community Pharmacies have played in delivering testing at the heart of communities across Northern Ireland. The ‘Universal Offer’, of which Pharmacy Collect is a key component, will continue to operate unchanged until 22 April.

In order to facilitate this, the contract with Alliance to supply tests to pharmacies across Northern Ireland has been extended until the end of April 2022. Community Pharmacies currently registered under the Pharmacy Collect scheme should continue to order lateral flow test kits via the established Alliance ordering process. There will be no change to order lead times or order limits up until 22 April 2022.

After this date it is likely that a revised model, focussing on supporting those most vulnerable in our society, will be required. Further communication on this new service will be shared in due course.

A letter from the Department of Health has been issued today (24 March) regarding Northern Ireland’s Test and Trace arrangements here.

The Test and Trace Transition Plan can be accessed online here.

ACTION

• Community Pharmacies currently registered under the Pharmacy Collect scheme should continue to order lateral flow test kits via the established Alliance ordering process.
• Please do not hesitate to contact the CPNI office should you require any further information.